ResearcherEnte Ospedaliero CantonaleNo recent work listed

Maria Celeste Palmarocchi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5033998532. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes. Co-author DOI 10.3390/cancers15184627 ↗
Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report. Co-author DOI 10.3892/ol.2017.6026 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sara De Dosso · 1 shared paper, 2023 · strength 0.17
- Paper Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metana… DOI 10.3390/cancers15184627 ↗
Raffaello Roesel · 1 shared paper, 2023 · strength 0.17
- Paper Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metana… DOI 10.3390/cancers15184627 ↗
Marco Cefalì · 1 shared paper, 2023 · strength 0.17
- Paper Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metana… DOI 10.3390/cancers15184627 ↗
Piercarlo Saletti · 1 shared paper, 2017 · strength 0.12
- Paper Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report. DOI 10.3892/ol.2017.6026 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.